The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
Best Life on MSN1d
Your Blood Pressure Reading Could Predict Your Risk of Cognitive Decline, New Study FindsRELATED: If You’re Over 65, This Supplement Could Lower Your Blood Pressure, New Research Shows. "Aggressive" blood pressure ...
Atrial fibrillation (AFib) can affect life expectancy due to factors that include age, underlying health conditions, race, and how this common cardiac arrhythmia—or abnormal heart rhythm— is treated.
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
A specially designed drug prevented laboratory mice from developing heart failure after heart attacks, according to new ...
Anti-CGRP antibodies vs onabotulinumtoxinA is not associated with increased cardiovascular disease risk in older patients ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...
New Scientist on MSN2d
GLP-1 drugs like Ozempic and Wegovy lower the risk of 42 conditionsThe benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...
A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different health outcomes. The findings show benefits for brain and heart health, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback